Hasan Jasem Al Nowais, the Group Chief Executive Officer and Managing Director of M42, a global tech-enabled healthcare company headquartered in Abu Dhabi, has been appointed as the Chairman of Cleveland Clinic Abu Dhabi’s newly constituted Board of Directors.
The hospital, which forms part of M42’s network of global healthcare providers, achieved a remarkable milestone by serving a record number of patients from both the UAE and around the world. Cleveland Clinic Abu Dhabi reported a substantial 20% increase in international patient numbers during the first half of 2023 compared to the same period in 2022.
Cleveland Clinic Abu Dhabi, a 400-bed hospital, was established in 2015 as a vital component of the Abu Dhabi government’s vision to create a world-class healthcare ecosystem. Following the renowned model of care provided by the U.S.-based Cleveland Clinic, this facility specializes in addressing a wide range of complex and critical healthcare needs. Earlier this year, the hospital inaugurated the Fatima bint Mubarak Center, a state-of-the-art facility dedicated to delivering cutting-edge, personalized care for cancer patients.
Commenting on his appointment, Hasan Jasem Al Nowais, the newly appointed Chairman of Cleveland Clinic Abu Dhabi, said, “In under ten years, Cleveland Clinic Abu Dhabi has built an impressive reputation as the leading complex care facility in the region. This is a testament to our partnership with Cleveland Clinic and the dedication of our world-class caregivers. Throughout the M42 network, we are actively realizing the government’s vision of providing world-class healthcare in Abu Dhabi.”
Cleveland Clinic Abu Dhabi has played a pivotal role in advancing educational and research initiatives aimed at enhancing the skills of current and future healthcare professionals, thereby positioning the UAE as a prominent knowledge hub in the healthcare sector.
Al Nowais further elaborated, stating, “M42, in collaboration with Cleveland Clinic, will continue to elevate the world-class facility in Abu Dhabi, ensuring the delivery of even more advanced services to the most critically ill patients. This partnership serves a dual purpose: integrating Cleveland Clinic’s high-quality care model across our network while harnessing M42’s innovative technologies, including AI and genomic sequencing, to provide precise, patient-centric, and preventive care.”
M42 represents a groundbreaking integrated healthcare company, merging G42 Healthcare’s distinctive medical and data-centric technologies with Mubadala Health’s provision of world-class care. M42 boasts a comprehensive global portfolio of health-tech and healthcare enterprises, encompassing over 450 facilities across 24 countries. The recent acquisition of Diaverum, the world’s third-largest dialysis provider, underscores M42’s commitment to expanding its healthcare footprint.
Cleveland Clinic Abu Dhabi, an integral component of the M42 network, has earned a prestigious reputation for its world-class complex care, positioning itself as the preferred choice for patients from around the world seeking specialized medical attention.
